FDA Green Lights Leqembi® Maintenance Dosing for Early Alzheimer’s Treatment

BioArctic AB’s partner Eisai publicized that the U.S. Food and Drug Administration (FDA) had accepted Eisai's Supplemental Biologics License Application…